Michael Burshtine
Directeur Général chez Adhestick Innovations Ltd.
Profil
Michael Burshtine is currently the Co-Chief Executive Officer at Adhestick Innovations Ltd.
He previously served as the President, Chief Executive Officer & Director at Flight Medical Innovations Ltd.
from 2011 to 2014, President & Chief Executive Officer at Recoly NV from 2007 to 2009, Independent Director at Bioblast Pharma Ltd.
from 2014 to 2018, Senior Partner at PricewaterhouseCoopers LLP from 2001 to 2004, and Chief Financial Officer at OMRIX Biopharmaceuticals, Inc. from 2004 to 2007.
He also worked as an Audit & Transaction Support Partner at Kesselman & Kesselman from 1999 to 2001.
Burshtine received his undergraduate and MBA degrees from Tel-Aviv University.
Postes actifs de Michael Burshtine
| Sociétés | Poste | Début |
|---|---|---|
| Adhestick Innovations Ltd. | Directeur Général | - |
Anciens postes connus de Michael Burshtine
| Sociétés | Poste | Fin |
|---|---|---|
Bioblast Pharma Ltd.
 Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | Directeur/Membre du Conseil | 31/07/2018 |
Flight Medical Innovations Ltd.
 Flight Medical Innovations Ltd. Medical SpecialtiesHealth Technology Flight Medical Innovations Ltd. engages in the development, manufacture, and marketing of versatile ventilators. Its products include Flight 60 and Vento2ux. The company was founded in 1963 and is headquartered Petach-Tikva, Israel. | Directeur Général | 01/05/2014 |
Recoly NV
 Recoly NV Miscellaneous Commercial ServicesCommercial Services Recoly NV operates as a biotech company focusing on the discovery, development and commercialization of drug enhancing technologies that are used to create bio-better drugs. Its pipeline includes multiple products; all based on their proprietary technologies, in different development stages from marketing authorization filing through pivotal to pre-clinical studies. The company was founded by Robert Taub in 1992 and is headquartered in Brussels, Belgium. | President | 01/01/2009 |
OMRIX Biopharmaceuticals, Inc.
 OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Directeur Financier/CFO | 31/08/2007 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | 01/04/2004 |
Formation de Michael Burshtine
| Tel-Aviv University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
OMRIX Biopharmaceuticals, Inc.
OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Kesselman & Kesselman
 Kesselman & Kesselman Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., Kesselman & Kesselman is an Israeli company that provides accounting services. The company is based in Tel Aviv, Israel. | Commercial Services |
Flight Medical Innovations Ltd.
Flight Medical Innovations Ltd. Medical SpecialtiesHealth Technology Flight Medical Innovations Ltd. engages in the development, manufacture, and marketing of versatile ventilators. Its products include Flight 60 and Vento2ux. The company was founded in 1963 and is headquartered Petach-Tikva, Israel. | Health Technology |
Recoly NV
Recoly NV Miscellaneous Commercial ServicesCommercial Services Recoly NV operates as a biotech company focusing on the discovery, development and commercialization of drug enhancing technologies that are used to create bio-better drugs. Its pipeline includes multiple products; all based on their proprietary technologies, in different development stages from marketing authorization filing through pivotal to pre-clinical studies. The company was founded by Robert Taub in 1992 and is headquartered in Brussels, Belgium. | Commercial Services |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | Health Technology |
| Adhestick Innovations Ltd. |
